Compare Abeona Therapeutics Inc (ABEO) vs American Homes 4 Rent Class A (AMH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs American Homes 4 Rent Class A — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while American Homes 4 Rent Class A trades at $33.36 (market cap $12.23B). The key difference: American Homes 4 Rent Class A is far larger — about 32.8× Abeona Therapeutics Inc's market cap, and American Homes 4 Rent Class A pays a 3.88% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | AMH | |
|---|---|---|
Market Cap | $373.32M | $12.23B |
Sector | Health | Real Estate |
52-Week High | $7.23 | $36.74 |
52-Week Low | $4.17 | $27.38 |
Enterprise Value | $228.22M | $17.32B |
Dividend Yield | — | 3.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
AMH trades at $34.00, down 0.23% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $35.41. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.35 exceeding expectations of $0.1763. Revenue grew to $1.85 billion in 2025, with a net income margin of 25.27%, while the stock trades at a P/E of 27.45 and P/S of 6.69. A dividend of $0.33 per share is scheduled for payment on June 30, 2026.
AMH presents a positive outlook driven by consistent earnings performance and robust fundamentals, though elevated valuation ratios and high debt levels pose risks. Investor sentiment is supported by bullish analyst ratings and strong occupancy rates in the single-family rental market, but macroeconomic factors and interest rate sensitivity remain key considerations for potential investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About American Homes 4 Rent Class A
American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Read more on AMH →
